alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1999
<PERIOD-START>                             OCT-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                       4,073,968
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                 60,067,767
<CURRENT-ASSETS>                             5,784,590
<PP&E>                                         250,191
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              75,902,708<F1>
<CURRENT-LIABILITIES>                       45,194,471
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       349,345
<OTHER-SE>                                  30,358,892
<TOTAL-LIABILITY-AND-EQUITY>                75,902,708
<SALES>                                     22,073,039
<TOTAL-REVENUES>                            22,869,339
<CGS>                                       19,826,265
<TOTAL-COSTS>                               19,826,265
<OTHER-EXPENSES>                             2,476,782
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,723
<INCOME-PRETAX>                                564,569
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            564,569
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   564,569
<EPS-BASIC>                                       0.02
<EPS-DILUTED>                                     0.02
<FN>
<F1>Includes $5,726,192 of Goodwill
</FN>


</TABLE>
<PAGE>

                                                                    EXHIBIT 23-b

The Board of Directors
AmSouth Bancorporation:


We consent to incorporation by reference in the following registration
statements of AmSouth Bancorporation of our report dated January 21, 1999,
relating to the consolidated balance sheets of First American Corporation and
subsidiaries as of December 31, 1998 and 1997, and the related consolidated
income statements, changes in shareholders' equity, and cash flows for each of
the years in the two-year period ended December 31, 1998, and all related
schedules, which report appears in the December 31, 1999, annual report on Form
10-K of AmSouth Bancorporation.

Form S-3 No. 33-55683 pertaining to the Dividend Reinvestment and Common Stock
     Purchase Plan;
Form S-8 No. 33-52243 pertaining to the assumption by AmSouth Bancorporation of
     FloridaBank Stock Option Plan and FloridaBank Stock Option Plan - 1993;
Form S-8 No. 33-52113 pertaining to the 1989 Long Term Incentive Compensation
     Plan;
Form S-8 No. 33-35218 pertaining to the 1989 Long Term Incentive Compensation
     Plan;
Form S-8 No. 33-37905 pertaining to the AmSouth Bancorporation Thrift Plan;
Form S-8 No. 33-2927 (as amended) pertaining to the Employee Stock Purchase
     Plan;
Form S-3 No. 33-35280 pertaining to the Dividend Reinvestment and Common Stock
     Purchase Plan;
Form S-8 No. 33-58777 pertaining to the Director Restricted Stock Plan;
Form S-8 No. 333-02099 pertaining to the AmSouth Bancorporation Thrift Plan;
Form S-8 No. 333-05631 pertaining to the AmSouth Bancorporation 1996 Long Term
     Incentive Compensation Plan;
Form S-8 No. 333-27107 pertaining to the AmSouth Bancorporation Employee Stock
     Purchase Plan;
Form S-8 No. 333-41599 pertaining to the AmSouth Bancorporation Deferred
     Compensation Plan and the Amended and Restated Deferred Compensation Plan
     for Directors of AmSouth Bancorporation;
Form S-3 No. 333-44263 pertaining to the AmSouth Bancorporation Shelf
     Registration Statement;
Form S-8 No. 333-76283 pertaining to the Stock Option Plan for Outside
     Directors;
Form S-8 No. 333-89451 pertaining to the First American Corporation 1993 Non-
     Employee
<PAGE>
Page 2

     Director Stock Option Plan;
Form S-8 No. 333-89455 pertaining to the First American Corporation 1999 Broad-
     Based Employee Stock Option Plan;
Form S-8 No. 333-89457 pertaining to the First American Corporation Star Award
     Plan;
Form S-8 No. 333-89459 pertaining to the Deposit Guaranty Corporation Long Term
     Incentive Plans;
Form S-8 No. 333-89461 pertaining to the First American Corporation 1991
     Employee Stock Incentive Plan;
Form S-8 No. 333-89463 pertaining to the Heritage Federal Bankshares, Inc. 1994
     Stock Option Plan for Non-Employee Directors and 1992 Stock Option Plan and
     Incentive Compensation Plan for Non-Employee Directors; and
Form S-8 No. 333-89633 pertaining to the First American Corporation First
     Incentives Reward Savings Thrift Plan.


/s/ KPMG LLP
------------------
KPMG LLP

Nashville, Tennessee
March 29, 2000
#### Kathleen Backus, Plaintiff, v John Backus, Defendant.

Supreme Court, Nassau County,

March 7, 1988

APPEARANCES OF COUNSEL

*Thomas Costello*for plaintiff. *John Backus,*defendant *pro se.*

OPINION OF THE COURT

Allan L. Winick, J.

The court declines to sign this judgment of divorce.

Plaintiff obtained a judgment of separation based upon cruel and inhuman treatment (Domestic Relations Law § 200 [1]) and judgment was entered on August 11, 1987. Plaintiff now moves for judgment of divorce based on the same allegations of cruel and inhuman treatment (Domestic Relations Law § 170 [1]). In support of her contention plaintiff cites *McKean v*
      *1043
      *McKean*(100 AD2d 537). In that case, the pendency of the separation action did not preclude the divorce action. The court went even further to state that a judgment in the separation action would not bar a divorce action. The *McKean*court relied on the case of *Hall v Hall*(150 App Div 688). In that case, the divorce action and separation action were based on different grounds. It was for that reason the court upheld plaintiff’s right to proceed.

However, in the instant case, the plaintiff alleges the same facts as the basis for the divorce and separation causes of action (cruel and inhuman treatment). This court finds that it cannot sign the judgment for two different reasons.

The first is the absence of allegations supporting the divorce action different than those which formed the basis of the separation judgment *(Conrad v Conrad,*124 App Div 780).

The second is a more fundamental reason for the rejection of this application.

Effective September 1, 1967, the Legislature amended the Domestic Relations Law by including section 170 (5) which set forth an additional ground for divorce based upon the existence of a judgment of separation for a period of two years or more. Effective September 1, 1972 the minimum period was reduced to one year.

To permit plaintiff in this case to convert her judgment of separation into a judgment of divorce by the method she proposes, is to circumvent the clear intention of the Legislature that at least one year pass before such judgment may be converted into a judgment of divorce.

The statement in *McKean (supra,*at 538) that, "Even if a separation had been granted in action No. 1, a subsequent action for divorce would have been proper” is not only dictum, but there is no indication that the grounds for separation were either the same or different or that the court even considered that issue.

This court specifically makes no ruling concerning the one-year waiting period and its applicability to a case where the underlying facts forming the basis of a cause of action for separation are different than those forming the basis of the divorce action.

This might be a matter for legislative consideration.
[Federal Register Volume 89, Number 211 (Thursday, October 31, 2024)]
[Notices]
[Page 86901]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-25352]


-----------------------------------------------------------------------

SMALL BUSINESS ADMINISTRATION

[Disaster Declaration #20751 and #20752; TENNESSEE Disaster Number TN-
20019]


Presidential Declaration Amendment of a Major Disaster for Public 
Assistance Only for the State of Tennessee

AGENCY: Small Business Administration.

ACTION: Amendment 1.

-----------------------------------------------------------------------

SUMMARY: This is an amendment of the Presidential declaration of a 
major disaster for Public Assistance Only for the State of Tennessee 
(FEMA-4832-DR), dated October 9, 2024.
    Incident: Tropical Storm Helene.

DATES: Issued on October 24, 2024.
    Incident Period: September 26, 2024 through September 30, 2024.
    Physical Loan Application Deadline Date: December 9, 2024.
    Economic Injury (EIDL) Loan Application Deadline Date: July 9, 
2025.

ADDRESSES: Visit the MySBA Loan Portal at https://lending.sba.gov to 
apply for a disaster assistance loan.

FOR FURTHER INFORMATION CONTACT: Alan Escobar, Office of Disaster 
Recovery & Resilience, U.S. Small Business Administration, 409 3rd 
Street SW, Suite 6050, Washington, DC 20416, (202) 205-6734.

SUPPLEMENTARY INFORMATION: The notice of the President's major disaster 
declaration for Private Non-Profit organizations in the State of 
Tennessee, dated October 9, 2024 is hereby amended to update the 
incident period for this disaster as beginning September 26, 2024 
through September 30, 2024.
    All other information in the original declaration remains 
unchanged.

(Catalog of Federal Domestic Assistance Number 59008)

Rafaela Monchek,
Deputy Associate Administrator, Office of Disaster Recovery & 
Resilience.
[FR Doc. 2024-25352 Filed 10-30-24; 8:45 am]
BILLING CODE 8026-09-P
DC9413.pdf -- Converted by SEC Publisher 4.2, created by BCL Technologies Inc., for SEC Filing








	
EXHIBIT 10.54







	
AMENDMENT NO. 3







RESEARCH COLLABORATION AND LICENSE AGREEMENT


This AMENDMENT NO. 3 (the
“Amendment”) is effective as of September 30, 2010 (the “Amendment Effective Date”), by and between AstraZeneca
AB, a company incorporated in Sweden under no. 556011-7482 with offices at S-151 85 Södertälje, Sweden (“AstraZeneca”) and Dynavax Technologies Corporation, a Delaware
corporation with offices at 2929 Seventh Street, Suite 100, Berkeley, California 94710-2753, USA (“Dynavax”).  AstraZeneca and Dynavax are sometimes referred to herein individually
as a “Party” and collectively as the “Parties.”


	
RECITALS







WHEREAS, the Parties are party to the Research Collaboration and License Agreement entered into as of September 1, 2006, as
amended (the “Agreement”), whereby the Parties entered into an agreement for the discovery and development of TLR-9 agonist-based therapies for the treatment of asthma and chronic
obstructive pulmonary disease; 


WHEREAS, the Parties now desire to amend the Agreement to amend Section 19.3. 


NOW, THEREFORE, the Parties, intending to be
legally bound, hereby agree as follows:


     1.1 Definitions. Terms used with initial capitals herein and not defined below shall have the meanings ascribed to them in the Agreement.


     1.2 Amendments. The following provisions of the Agreement are amended as set forth below. 


     (a) Section 19.3. Section 19.3 of the Agreement is hereby amended to read in full as follows:


     “Regents Indemnity; AstraZeneca. In addition to any other remedy available to AstraZeneca, Dynavax shall indemnify defend and hold
harmless AstraZeneca, its Affiliates, Distributors, Sublicensees and its and their respective directors, officers and employees in full and on demand, from and against any and all Losses incurred by them to the extent resulting from or arising out
of or in connection with any breach by Dynavax of its obligations pursuant to the Regents Agreement referenced in Section 10.5, excluding any breach directly arising from breach of this Agreement by AstraZeneca.”


     1.3 Governing Law. This Amendment shall be governed by and construed under the substantive laws of the State of Delaware, excluding any conflict of law rule or
principle that might otherwise refer construction or interpretation of this Amendment to the substantive law of another jurisdiction.











     1.4 Continuing Effect. The Agreement, as hereby amended, remains in full force and effect.


     IN WITNESS WHEREOF, each of the Parties have agreed to and accepted the foregoing Amendment and have caused this Amendment to be signed by their duly authorized representatives on the Amendment Effective
Date.

	
DYNAVAX TECHNOLOGIES CORPORATION 
		
 		
ASTRAZENECA AB 
	
	
By: 
		
 		
/s/ Michael S. Ostrach 
		
 		
By: 
		
 		
/s/ Anders Buren 
	
	


		
		


		
		


		
		


	
	
Name: 
		
 		
Michael S. Ostrach 
		
 		
Name: 
		
 		
Anders Buren 
	
	
		
		


		
		
		
		


	
	
Title: 
		
 		
Vice President 
		
 		
Title: 
		
 		
Authorized Signatory
**Exhibit 23(d)1**

 

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

 

We consent to the incorporation by reference in Registration Statement Nos. 333-138480 and 333-149664 on Form S-3 of our reports dated February 25, 2009, relating to the financial statements and financial statement schedule of Gulf Power Company, appearing in this Annual Report on Form 10-K of Gulf Power Company for the year ended December 31, 2008.

/s/Deloitte & Touche LLP

Atlanta, Georgia

February 25, 2009
Exhibit
      32








OFFICER'S
      CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF
      2002








In
      connection with the filing by Tix Corporation (the “Company”) of its Quarterly
      Report on Form 10-QSB for the quarterly period ended March 31, 2007 (the
“Quarterly Report”) with the Securities and Exchange Commission, I, Mitch
      Francis, Chief Executive Officer and Chief Financial Officer of the Company,
      certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
      906
      of the Sarbanes-Oxley Act of 2002, that:





(1)
      The
      Quarterly Report fully complies with the requirements of Section 13(a) or 15(d)
      of the Securities Exchange Act of 1934; and





(2)
      The
      information contained in the Quarterly Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.





A
      signed
      original of this written statement required by Section 906 has been provided
      to
      the Company and will be retained by the Company and furnished to the Securities
      and Exchange Commission or its staff upon request.




Date: May
                17, 2007
              By:
              /s/ MITCH
                FRANCISMitch
                Francis
                Chief
                  Executive Officer and
                Chief
                  Financial Officer
<TABLE> <S> <C>


<ARTICLE>                  5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM SCANTEK
MEDICAL, INC. FINANCIAL STATEMENTS AT DECEMBER 31, 2000 AND THE SIX MONTHS THEN
ENDED AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER>      1

<S>                                  <C>
<PERIOD-TYPE>                       12-MOS
<FISCAL-YEAR-END>                   JUN-30-2000
<PERIOD-END>                        DEC-31-2000
<CASH>                                                            12,959
<SECURITIES>                                                       2,806
<RECEIVABLES>                                                     24,000
<ALLOWANCES>                                                           0
<INVENTORY>                                                      594,528
<CURRENT-ASSETS>                                                 634,293
<PP&E>                                                         2,102,060
<DEPRECIATION>                                                   703,774
<TOTAL-ASSETS>                                                 2,099,949
<CURRENT-LIABILITIES>                                          5,797,672
<BONDS>                                                                0
<COMMON>                                                          19,316
<PREFERRED-MANDATORY>                                                  0
<PREFERRED>                                                            0
<OTHER-SE>                                                    (5,903,148)
<TOTAL-LIABILITY-AND-EQUITY>                                   2,099,949
<SALES>                                                           21,137
<TOTAL-REVENUES>                                                  21,137
<CGS>                                                            291,861
<TOTAL-COSTS>                                                    883,881
<OTHER-EXPENSES>                                                 253,367
<LOSS-PROVISION>                                                       0
<INTEREST-EXPENSE>                                               280,386
<INCOME-PRETAX>                                               (1,116,111)
<INCOME-TAX>                                                           0
<INCOME-CONTINUING>                                           (1,116,111)
<DISCONTINUED>                                                         0
<EXTRAORDINARY>                                                        0
<CHANGES>                                                              0
<NET-INCOME>                                                  (1,116,111)
<EPS-BASIC>                                                         (.06)
<EPS-DILUTED>                                                       (.06)



</TABLE>
##### 



Exhibit 32.2 Certification of CFO Pursuant to
18 U.S.C. Section 1350,
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the Quarterly Report of AIMCO Properties, L.P. (the Company) on Form 10-Q for
the period ending March 31, 2005 as filed with the Securities and Exchange Commission on the date
hereof (the Report), I, Paul J. McAuliffe, as Chief Financial Officer of the Company hereby
certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of
2002, to the best of my knowledge, that: (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the
financial condition and result of operations of the Company.  /s/ Paul J. McAuliffe
No. 156—2270.

#### The Louisville, New Albany *&*Chicago Ry. Co. v. Robert M. Cherrie et al.

This is an appeal from a judgment for $748.43, obtained in the court below by appellees, Cherrie & Co., against appellant, for commissions claimed to have been earned in the purchase of railroad materials. There is no pretense that appellant, the defendant below, ever employed Cherrie *&*Co., the plaintiffs, to make *647any such purchases ; but the latter sought to establish their right of recovery, by showing that February 12, 1880, the Chicago *&*Indianapolis Air Line Bail way Company, through Henry Crawford as treasurer, entered into a special contract with them in writing,' by which that company agreed to pay plaintiff the commissions in question, and that subsequently, and before this suit, said last named railway pompany became consolidated with the appellant company, by reason whereof the latter company became, liable to pay said commissions to plaintiffs. The special contract was not declared upon, and there was no evidence under a *quantum meruit.*It was therefore necessary to support the finding of the court below (the case being tried without a jury), that evidence should have been adduced tending to show, either that said railway company had previously authorized said Crawford to make said special contract on its behalf, or that, with knowledge of all material facts, it had subsequently ratified his act in doing so. As the case is totally barren of evidence upon either a pre. vio us or subsisting authority, or subsequent ratification, the judgment is reversed.

J%dge below, Elliott Anthony.

Attorneys, for appellant, Mr. Geo. W. Easley and Mr. W. H. Low;

for appellees, Mr. Frederic Ullmann.

Opinion filed March 31, 1886.

Opinion by McAllister, J.
Exhibit 99.14  CONSENT OF MARC LEGAULT  I consent to the inclusion in the Annual Report on Form 40-F of Agnico Eagle Mines Limited for the year ended December 31, 2017 filed with the Securities and Exchange Commission on March 29, 2018 (the Annual Report) of my name and the information that I have approved of as a qualified person under the Canadian Securities Administrators National Instrument 43-101 in the Annual Information Form of Agnico Eagle Mines Limited dated March 23, 2018 (the AIF) filed as part of the Annual Report.  I also consent to the incorporation by reference in the Registration Statements on Form F-10 (registration no. 333-221636), Form F-3D (registration no. 333-215096) and Form S-8 (registration nos. 333-130339 and 333-152004) of the reference to my name and the above-mentioned information in the AIF.  March 29, 2018/s/   Marc LegaultMarc   LegaultSenior   Vice-President, Operations